SMALL MOLECULE
5-Amino-1MQ
5-Amino-1MQ (5-amino-1-methylquinoline) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cell...
CATEGORY
8 compounds tracked in this category with source-backed claims and regulatory status.
SMALL MOLECULE
5-Amino-1MQ (5-amino-1-methylquinoline) is a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT), an enzyme involved in cell...
3 claims · 2 sources · Regulatory watch
HGH FRAGMENT PEPTIDE (LIPOLYTIC)
AOD-9604 is a synthetic peptide corresponding to the C-terminal fragment of human growth hormone (hGH) residues 177-191, developed by Metabo...
3 claims · 3 sources · Regulatory watch
ANGIOTENSIN IV ANALOG / HEPATOCYTE GROWTH FACTOR ACTIVATOR (COGNITIVE ENHANCEMENT)
Dihexa (N-hexanoic-tyr-ile-(6) aminohexanoic amide) is a metabolically stabilized analog of angiotensin IV developed by researchers at Washi...
3 claims · 5 sources · Research watch — preclinical only
LONGEVITY SMALL MOLECULE
Metformin is an FDA-approved biguanide antidiabetic (marketed as Glucophage and generics) used as first-line therapy for Type 2 diabetes. It...
4 claims · 6 sources · Evidence review
MITOCHONDRIAL PEPTIDE
MOTS-c is a peptide topic commonly associated with metabolic and longevity discussions online. This starter page keeps the topic in the revi...
1 claims · 2 sources · Regulatory watch
GLP-1/GIP/GLUCAGON TRIPLE RECEPTOR AGONIST
Retatrutide is an investigational triple-agonist peptide (GLP-1, GIP, and glucagon receptor agonist) developed by Eli Lilly that showed sign...
4 claims · 6 sources · Regulatory watch
GLP-1 RECEPTOR AGONIST
Semaglutide (Ozempic/Wegovy/Rybelsus) is a GLP-1 receptor agonist developed by Novo Nordisk, FDA-approved for Type 2 diabetes and chronic we...
4 claims · 11 sources · Evidence review
DUAL GIP/GLP-1 RECEPTOR AGONIST
Tirzepatide (Mounjaro/Zepbound) is a dual GIP and GLP-1 receptor agonist developed by Eli Lilly, FDA-approved for Type 2 diabetes and chroni...
4 claims · 9 sources · Evidence review